A miniature device developed at the University of Montreal can measure a patient's blood for methotrexate in less than a minute. The latter is a commonly used, but potentially toxic cancer drug. Just as accurate and ten times less expensive than equipment currently used in hospitals, this nanoscale device has an optical system that can rapidly gauge the optimal dose of methotrexate a patient needs, while minimizing the drug's adverse effects. The research was led ...
Read More
You have just read an article categorized health
titled Cancer Treatment Monitoring can be Improved by New Nanodevice.
Written by:
editor -
Monday, October 27, 2014
There are currently no comments for "Cancer Treatment Monitoring can be Improved by New Nanodevice"
Post a Comment